Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Elashoff

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Statistics in Medicine|November 25, 2006
An approach to joint analysis of longitudinal measurements and competing risks failure time dataRobert M Elashoff, Gang Li, Ning Li
Biometrical Journal. Biometrische Zeitschrift|February 7, 2009
Robust joint modeling of longitudinal measurements and competing risks failure time dataNing Li, Robert M Elashoff, Gang Li
The New England Journal of Medicine|July 12, 2018
A Trial of Blood-Pressure Reduction in Black BarbershopsRonald G Victor, Ciantel Blyler, Robert M Elashoff
Statistics in Medicine|March 12, 2011
A method to estimate treatment efficacy among latent subgroups of a randomized clinical trialLily L Altstein, Gang Li, Robert M Elashoff
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1974
Statistical estimations in pharmacokineticsH G Boxenbaum, S Riegelman, R M Elashoff
Lifetime Data Analysis|June 16, 2010
A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effectsXin Huang, Gang Li, Robert M Elashoff, et al.
Journal of the National Cancer Institute|September 1, 1987
Statistical analysis of a carcinogen mixture experiment. I. Liver carcinogensR M Elashoff, T R Fears, M A Schneiderman
Annual Review of Public Health|January 1, 1997
Censoring issues in survival analysisK M Leung, R M Elashoff, A A Afifi
Toxicology and Industrial Health|June 1, 1988
The statistical analysis of a carcinogen mixture experiment. II. Carcinogens with different target organs, N-methyl-N'-nitro-N-nitrosoguanidine, N-butyl-N-(4-hydroxybutyl)nitrosamine, dipentylnitrosamine, and nitrilotriacetic acidT R Fears, R M Elashoff, M A Schneiderman
Statistics in Medicine|November 28, 2009
Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt-PA stroke trialNing Li, Robert M Elashoff, Gang Li, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Statistics in Medicine|November 25, 2006
An approach to joint analysis of longitudinal measurements and competing risks failure time dataRobert M Elashoff, Gang Li, Ning Li
Biometrical Journal. Biometrische Zeitschrift|February 7, 2009
Robust joint modeling of longitudinal measurements and competing risks failure time dataNing Li, Robert M Elashoff, Gang Li
The New England Journal of Medicine|July 12, 2018
A Trial of Blood-Pressure Reduction in Black BarbershopsRonald G Victor, Ciantel Blyler, Robert M Elashoff
Statistics in Medicine|March 12, 2011
A method to estimate treatment efficacy among latent subgroups of a randomized clinical trialLily L Altstein, Gang Li, Robert M Elashoff
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1974
Statistical estimations in pharmacokineticsH G Boxenbaum, S Riegelman, R M Elashoff
Lifetime Data Analysis|June 16, 2010
A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effectsXin Huang, Gang Li, Robert M Elashoff, et al.
Journal of the National Cancer Institute|September 1, 1987
Statistical analysis of a carcinogen mixture experiment. I. Liver carcinogensR M Elashoff, T R Fears, M A Schneiderman
Annual Review of Public Health|January 1, 1997
Censoring issues in survival analysisK M Leung, R M Elashoff, A A Afifi
Toxicology and Industrial Health|June 1, 1988
The statistical analysis of a carcinogen mixture experiment. II. Carcinogens with different target organs, N-methyl-N'-nitro-N-nitrosoguanidine, N-butyl-N-(4-hydroxybutyl)nitrosamine, dipentylnitrosamine, and nitrilotriacetic acidT R Fears, R M Elashoff, M A Schneiderman
Statistics in Medicine|November 28, 2009
Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt-PA stroke trialNing Li, Robert M Elashoff, Gang Li, et al.
Pageof 15